Literature DB >> 21874146

Drug-induced Liver Injury.

Stefan David1, James P Hamilton.   

Abstract

Drug-induced liver injury (DILI) is common and nearly all classes of medications can cause liver disease. Most cases of DILI are benign, and improve after drug withdrawal. It is important to recognize and remove the offending agent as quickly as possible to prevent the progression to chronic liver disease and/or acute liver failure. There are no definite risk factors for DILI, but pre-existing liver disease and genetic susceptibility may predispose certain individuals. Although most patients have clinical symptoms that are identical to other liver diseases, some patients may present with symptoms of systemic hypersensitivity. Treatment of drug and herbal-induced liver injury consists of rapid drug discontinuation and supportive care targeted to alleviate unwanted symptoms.

Entities:  

Year:  2010        PMID: 21874146      PMCID: PMC3160634     

Source DB:  PubMed          Journal:  US Gastroenterol Hepatol Rev        ISSN: 1758-3934


  182 in total

Review 1.  Safety issues with statin therapy.

Authors:  Robert L Talbert
Journal:  J Am Pharm Assoc (2003)       Date:  2006 Jul-Aug

2.  Acute hepatitis induced by greater celandine (Chelidonium majus).

Authors:  J Benninger; H T Schneider; D Schuppan; T Kirchner; E G Hahn
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

3.  Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.

Authors:  Claude Gagné; Harold E Bays; Stuart R Weiss; Pedro Mata; Katherine Quinto; Michael Melino; Meehyung Cho; Thomas A Musliner; Barry Gumbiner
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

Review 4.  The role of metabolic activation in drug-induced hepatotoxicity.

Authors:  B Kevin Park; Neil R Kitteringham; James L Maggs; Munir Pirmohamed; Dominic P Williams
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

5.  Ketoconazole-induced liver damage.

Authors:  J A Findor; J A Sorda; E B Igartua; A Avagnina
Journal:  Medicina (B Aires)       Date:  1998       Impact factor: 0.653

6.  Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases.

Authors:  S Iwarson; J Lindberg; P Lundin
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

7.  Erythromycin-associated cholestatic hepatitis.

Authors:  L E Derby; H Jick; D A Henry; A D Dean
Journal:  Med J Aust       Date:  1993-05-03       Impact factor: 7.738

8.  Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts.

Authors:  E De Lazzari; A León; J A Arnaiz; E Martinez; H Knobel; E Negredo; B Clotet; J Montaner; S Storfer; M A Asenjo; J Mallolas; J M Miró; J M Gatell
Journal:  HIV Med       Date:  2008-04       Impact factor: 3.180

9.  [Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance].

Authors:  A Castot; D Larrey
Journal:  Gastroenterol Clin Biol       Date:  1992

10.  Acute hepatitis induced by Greater Celandine (Chelidonium majus).

Authors:  F Stickel; G Pöschl; H K Seitz; R Waldherr; E G Hahn; D Schuppan
Journal:  Scand J Gastroenterol       Date:  2003-05       Impact factor: 2.423

View more
  42 in total

1.  Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs.

Authors:  Yaqing Wang; Wentao Su; Li Wang; Lei Jiang; Yang Liu; Lijian Hui; Jianhua Qin
Journal:  Toxicol Res (Camb)       Date:  2017-09-28       Impact factor: 3.524

2.  Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery.

Authors:  Hiroaki Nozawa; Shigenobu Emoto; Hirofumi Sonoda; Kazushige Kawai; Kazuhito Sasaki; Manabu Kaneko; Koji Murono; Hiroaki Ishii; Soichiro Ishihara
Journal:  Dig Dis Sci       Date:  2020-09-05       Impact factor: 3.199

3.  Peri-operative derangement in liver function tests in older patients with neck of femur fracture.

Authors:  J Powell; A Michael
Journal:  Osteoporos Int       Date:  2021-01-18       Impact factor: 4.507

4.  In silico approaches in organ toxicity hazard assessment: current status and future needs in predicting liver toxicity.

Authors:  Arianna Bassan; Vinicius M Alves; Alexander Amberg; Lennart T Anger; Scott Auerbach; Lisa Beilke; Andreas Bender; Mark T D Cronin; Kevin P Cross; Jui-Hua Hsieh; Nigel Greene; Raymond Kemper; Marlene T Kim; Moiz Mumtaz; Tobias Noeske; Manuela Pavan; Julia Pletz; Daniel P Russo; Yogesh Sabnis; Markus Schaefer; David T Szabo; Jean-Pierre Valentin; Joerg Wichard; Dominic Williams; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2021-09-09

5.  Doxycycline-induced cholestatic liver injury.

Authors:  Sanskriti Varma; John Nathanson; Mitra Dowlatshahi; Armando Del Portillo; Ivonne Ramirez; Reuben Garcia-Carrasquillo
Journal:  Clin J Gastroenterol       Date:  2021-07-06

6.  Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury.

Authors:  Linhao Li; Hongbing Wang; Jace W Jones
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-09-30       Impact factor: 3.072

7.  Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System.

Authors:  Nicholas Moore; Stéphanie Duret; Adeline Grolleau; Régis Lassalle; Vanessa Barbet; Mai Duong; Nicolas Thurin; Cécile Droz-Perroteau; Sinem Ezgi Gulmez
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

8.  Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity.

Authors:  Kevin J Downes; Jennifer L Goldman
Journal:  Clin Pharmacol Ther       Date:  2021-02-27       Impact factor: 6.875

9. 

Authors:  Alexander Kumachev; Peter E Wu
Journal:  CMAJ       Date:  2021-05-17       Impact factor: 8.262

10.  Prediction of Alternative Drug-Induced Liver Injury Classifications Using Molecular Descriptors, Gene Expression Perturbation, and Toxicology Reports.

Authors:  Wojciech Lesiński; Krzysztof Mnich; Witold R Rudnicki
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.